MTOR and non-small cell lung carcinoma: In addition, miR-208a packed in exosomes from A549 NSCLC cells was found to operate as a transfer messenger, target p21, and activate the AKT/mechanistic target of rapamycin (mTOR) pathway, limiting NSCLC cell growth [117].